Inspire Medical Systems (NYSE:INSP) Shares Up 4% – Still a Buy?

Inspire Medical Systems, Inc. (NYSE:INSP) shares were up 4% on Monday. The company traded as high as $71.66 and last traded at $71.6680. Approximately 119,753 shares were traded during trading, a decline of 89% from the average session volume of 1,067,725 shares. The stock had previously closed at $68.89.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the stock. Mizuho increased their price objective on shares of Inspire Medical Systems from $55.00 to $65.00 and gave the company an “outperform” rating in a research note on Tuesday, August 4th. Robert W. Baird lifted their target price on shares of Inspire Medical Systems from $54.00 to $59.00 and gave the company a “neutral” rating in a research report on Tuesday, August 4th. Weiss Ratings upgraded shares of Inspire Medical Systems from a “sell (d)” rating to a “sell (d+)” rating in a research report on Tuesday, September 22nd. Piper Sandler upped their target price on shares of Inspire Medical Systems from $55.00 to $60.00 and gave the company a “neutral” rating in a research note on Tuesday, August 4th. Finally, Freedom Capital raised shares of Inspire Medical Systems to a “strong-buy” rating in a research report on Tuesday, June 30th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, twelve have issued a Hold rating and four have given a Sell rating to the stock. According to MarketBeat.com, Inspire Medical Systems currently has a consensus rating of “Hold” and an average target price of $67.29.

Inspire Medical Systems Stock Up 4.3%

The stock’s 50-day moving average price is $65.23 and its 200-day moving average price is $54.18. The company has a market capitalization of $2.08 billion, a price-to-earnings ratio of 15.55, a price-to-earnings-growth ratio of 5.21 and a beta of 0.73.

Inspire Medical Systems (NYSE:INSP) last announced its quarterly earnings data on Monday, August 3rd. The company reported $0.14 earnings per share for the quarter, topping the consensus estimate of ($0.24) by $0.38. Inspire Medical Systems had a return on equity of 8.64% and a net margin of 15.03%. The firm had revenue of $200.58 million during the quarter, compared to analysts’ expectations of $194.72 million. During the same period in the previous year, the business posted $0.45 EPS. The company’s quarterly revenue was down 7.6% compared to the same quarter last year. Inspire Medical Systems has set its FY 2026 guidance at 1.050-1.450 EPS. On average, equities research analysts anticipate that Inspire Medical Systems, Inc. will post 1.24 EPS for the current year.

Insider Transactions at Inspire Medical Systems

In other Inspire Medical Systems news, insider Jason Kelly sold 963 shares of the firm’s stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $59.55, for a total transaction of $57,346.65. Following the sale, the insider directly owned 18,985 shares in the company, valued at approximately $1,130,556.75. This trade represents a 4.83% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 2.20% of the company’s stock.

Hedge Funds Weigh In On Inspire Medical Systems

A number of large investors have recently bought and sold shares of INSP. GAMMA Investing LLC grew its position in Inspire Medical Systems by 25.0% in the third quarter. GAMMA Investing LLC now owns 1,526 shares of the company’s stock valued at $106,000 after purchasing an additional 305 shares in the last quarter. Valeo Financial Advisors LLC bought a new stake in Inspire Medical Systems during the 3rd quarter worth about $229,000. Envestnet Portfolio Solutions Inc. bought a new stake in Inspire Medical Systems during the 2nd quarter worth about $296,000. WINTON GROUP Ltd lifted its position in Inspire Medical Systems by 790.8% during the 2nd quarter. WINTON GROUP Ltd now owns 37,412 shares of the company’s stock worth $1,669,000 after buying an additional 33,212 shares in the last quarter. Finally, Integrated Wealth Concepts LLC acquired a new position in shares of Inspire Medical Systems during the 2nd quarter worth about $131,000. Institutional investors and hedge funds own 94.91% of the company’s stock.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc is a medical technology company focused on developing and commercializing treatments for obstructive sleep apnea (OSA), a condition in which the upper airway repeatedly becomes blocked during sleep. The company’s primary product is the Inspire therapy system, an implantable device designed for certain adults with moderate to severe OSA who are unable to use or obtain consistent benefits from continuous positive airway pressure (CPAP) therapy.

The Inspire system uses an implantable pulse generator, a stimulation lead and a sensing lead.